1-4 of 4
Surender Kharbanda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B40: Concomitant delivery of paclitaxel and NuBCP9 peptide, for the enhancement of synergistic effect, in cancer therapy

Dikshi Gupta, Sumeet Kapoor, Priyanka Tyagi, Manoj Kumar, Amit Kumar Tyagi, Surender Kharbanda, Harpal Singh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B40.
https://doi.org/10.1158/1535-7163.TARG-15-B40
Published: 01 December 2015
View article titled, Abstract B40: Concomitant delivery of paclitaxel and NuBCP9 peptide, for the enhancement of synergistic effect, in cancer therapy
Journal Articles

Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells

Deepak Raina, Michio Kosugi, Rehan Ahmad, Govind Panchamoorthy, Hasan Rajabi, Maroof Alam, Takeshi Shimamura, Geoffrey I. Shapiro, Jeffrey Supko, Surender Kharbanda, Donald Kufe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (5): 806–816.
https://doi.org/10.1158/1535-7163.MCT-10-1050
Published: 08 May 2011
View article titled, Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells
Open the PDF for Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

MUC1 oncoprotein is a druggable target in human prostate cancer cells

Maya Datt Joshi, Rehan Ahmad, Li Yin, Deepak Raina, Hasan Rajabi, Glenn Bubley, Surender Kharbanda, Donald Kufe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 3056–3065.
https://doi.org/10.1158/1535-7163.MCT-09-0646
Published: 10 November 2009
View article titled, MUC1 oncoprotein is a druggable target in human prostate cancer cells
Open the PDF for MUC1 oncoprotein is a druggable target in human prostate cancer cells in another window
Includes: Supplementary data
Journal Articles

The Novel Isocoumarin 2-(8-Hydroxy-6-methoxy-1-oxo-1H -2-benzopyran-3-yl) Propionic Acid (NM-3) Induces Lethality of Human Carcinoma Cells by Generation of Reactive Oxygen Species

Li Yin, Tsuneya Ohno, Ralph Weichselbaum, Surender Kharbanda, Donald Kufe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2001) 1 (1): 43–48.
Published: 01 November 2001
View article titled, The Novel Isocoumarin 2-(8-Hydroxy-6-methoxy-1-oxo-1<em>H</em> -2-benzopyran-3-yl) Propionic Acid (NM-3) Induces Lethality of Human Carcinoma Cells by Generation of Reactive Oxygen Species
Open the PDF for The Novel Isocoumarin 2-(8-Hydroxy-6-methoxy-1-oxo-1<em>H</em> -2-benzopyran-3-yl) Propionic Acid (NM-3) Induces Lethality of Human Carcinoma Cells by Generation of Reactive Oxygen Species in another window